MCID: LYM019
MIFTS: 53

Lymphosarcoma malady

Categories: Rare diseases, Cancer diseases, Immune diseases

Aliases & Classifications for Lymphosarcoma

Summaries for Lymphosarcoma

MalaCards based summary : Lymphosarcoma, also known as malignant lymphoma, is related to mediastinal malignant lymphoma and burkitt lymphoma. An important gene associated with Lymphosarcoma is NR3C1 (Nuclear Receptor Subfamily 3 Group C Member 1), and among its related pathways/superpathways are Chromatin Regulation / Acetylation and Cell adhesion molecules (CAMs). The drugs Dexamethasone and Doxorubicin have been mentioned in the context of this disorder. Affiliated tissues include lymph node, t cells and lung, and related phenotypes are cardiovascular system and cellular

Wikipedia : 71 Lymphoma is a group of blood cell tumors that develop from lymphocytes (a type of white blood cell). The... more...

Related Diseases for Lymphosarcoma

Diseases related to Lymphosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 100)
id Related Disease Score Top Affiliating Genes
1 mediastinal malignant lymphoma 11.9
2 burkitt lymphoma 11.4
3 mantle cell lymphoma 11.2
4 breast lymphoma 11.1
5 lymphoproliferative syndrome, x-linked, 1 11.0
6 lymphoproliferative syndrome 2 10.9
7 testicular lymphoma 10.9
8 leukemia 10.3
9 viral meningitis 10.2 G6PD H6PD
10 endometriosis of uterus 10.2 G6PD H6PD
11 penile disease 10.1 CD22 PTPRC
12 dermatophytosis 10.1 CD40LG CTSL
13 lambda 5 deficiency 10.1 CD40LG PTPRC
14 mental retardation hypocupremia hypobetalipoproteinemia 10.1 G6PD GSR
15 abdominal tuberculosis 10.1 CD40LG CTSL
16 mild pre-eclampsia 10.1 CD22 CD40LG
17 akinetopsia 10.0 CD40LG PTPRC
18 somatostatinoma 10.0 CD22 CTSL PTPRC
19 clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly 10.0 BCL2 NR3C1
20 lymphoma 10.0
21 reticulosarcoma 9.9
22 leukemia, acute lymphoblastic 3 9.9
23 conduct disorder 9.9 CD40LG G6PD
24 spastic paraplegia 52, autosomal recessive 9.8 BCL2 SMARCA4
25 hepatitis 9.8
26 mediastinitis 9.8
27 inflammatory bowel disease 9.7
28 hypersplenism 9.7
29 neuropathy 9.7
30 ataxia 9.7
31 acute leukemia 9.6
32 lymphoid leukemia 9.6
33 thrombosis 9.6
34 pericardial effusion 9.6
35 uveitis 9.6
36 plasmacytoma 9.6
37 histiocytoma 9.6
38 pneumonia 9.6
39 hodgkin's granuloma 9.6
40 myeloid leukemia 9.6
41 paraneoplastic syndromes 9.6
42 obesity 9.5
43 holt-oram syndrome 9.5
44 lymphoid interstitial pneumonia 9.5
45 congestive heart failure 9.5
46 gastric cancer 9.5
47 glomerulonephritis 9.5
48 hemolytic anemia 9.5
49 hydrocephalus 9.5
50 lymphedema 9.5

Graphical network of the top 20 diseases related to Lymphosarcoma:



Diseases related to Lymphosarcoma

Symptoms & Phenotypes for Lymphosarcoma

MGI Mouse Phenotypes related to Lymphosarcoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.8 BCL2 CD40LG DNMT3A G6PD GSR NR3C1
2 cellular MP:0005384 9.76 BCL2 CD22 CD40LG DNMT3A G6PD NR3C1
3 endocrine/exocrine gland MP:0005379 9.5 BCL2 CD40LG DNMT3A H6PD NR3C1 PTPRC
4 mortality/aging MP:0010768 9.28 PTPRC RRP8 SMARCA4 BCL2 CD22 CD40LG

Drugs & Therapeutics for Lymphosarcoma

Drugs for Lymphosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 895)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-02-2 5743
2
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 23214-92-8 31703
3
Daunorubicin Approved Phase 4,Phase 3,Phase 2,Phase 1 20830-81-3 30323
4
Vinblastine Approved Phase 4,Phase 3,Phase 2,Phase 1 865-21-4 13342 241903
5
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 2068-78-2, 57-22-7 5978
6
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
7
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
8
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 147-94-4 6253
9
Teniposide Approved Phase 4,Phase 3,Phase 2,Phase 1 29767-20-2 34698
10
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1959-05-2, 59-05-2 126941
11
Melphalan Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 148-82-3 4053 460612
12
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
13
Iron Approved Phase 4,Phase 3,Phase 1,Phase 2 7439-89-6 23925
14
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1 95058-81-4 60750
15
Tenofovir Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 147127-20-6 464205
16
Fludarabine Approved Phase 4,Phase 3,Phase 2,Phase 1 21679-14-1, 75607-67-9 30751
17
Vidarabine Approved Phase 4,Phase 3,Phase 2,Phase 1 24356-66-9 32326 21704
18
Busulfan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 55-98-1 2478
19
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 174722-31-7 10201696
20
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-23-7 5754 657311
21
Bleomycin Approved Phase 4,Phase 3,Phase 2,Phase 1 11056-06-7 5360373
22
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 3778-73-2 3690
23
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
24
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
25
Mechlorethamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-75-2 4033
26
Oxaliplatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 61825-94-3 5310940 9887054 6857599, 9887054 43805
27
Mesna Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 3375-50-6 598
28
Dacarbazine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 4342-03-4 5351166
29
Bexarotene Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 153559-49-0 82146
30
Clarithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1 81103-11-9 84029
31
Granisetron Approved, Investigational Phase 4,Phase 2 109889-09-0 3510
32
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
33
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2 26787-78-0 33613 2171
34
Metronidazole Approved Phase 4,Phase 3,Phase 2 443-48-1 4173
35
Tropisetron Approved, Investigational Phase 4 105826-92-4, 89565-68-4 5595
36
Amifostine Approved, Investigational Phase 4,Phase 2,Phase 1 20537-88-6 2141
37
Thiotepa Approved Phase 4,Phase 3,Phase 2,Phase 1 52-24-4 5453
38
Lenograstim Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 135968-09-1
39
Aprepitant Approved, Investigational Phase 4,Phase 2,Phase 1,Early Phase 1 170729-80-3 151165 6918365
40
Denileukin diftitox Approved, Investigational Phase 4,Phase 2,Phase 1 173146-27-5
41
Entecavir Approved, Investigational Phase 4,Phase 2 142217-69-4 153941
42
Palonosetron Approved, Investigational Phase 4,Phase 2 135729-61-2, 119904-90-4, 135729-56-5 148211
43
Menthol Approved Phase 4,Phase 3,Phase 1,Phase 2 2216-51-5 16666
44
Cladribine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 4291-63-8 20279
45
Thioguanine Approved Phase 4,Phase 3,Phase 2,Phase 1 154-42-7 2723601
46
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
47
Fosaprepitant Approved Phase 4,Phase 2,Phase 1,Early Phase 1 172673-20-0 219090
48
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
49
Methoxsalen Approved Phase 4,Phase 3,Phase 2,Phase 1 298-81-7 4114
50
Vindesine Approved Phase 4,Phase 3,Phase 2,Phase 1 59917-39-4, 53643-48-4 40839

Interventional clinical trials:

(show top 50) (show all 5000)
id Name Status NCT ID Phase
1 Lymphoma in the Orbit Unknown status NCT01302912 Phase 4
2 Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old. Unknown status NCT00429065 Phase 4
3 Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults Unknown status NCT00797810 Phase 4
4 Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET Unknown status NCT00188149 Phase 4
5 Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) Unknown status NCT02347878 Phase 4
6 Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice Unknown status NCT01273441 Phase 4
7 An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease. Completed NCT00440817 Phase 4
8 Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America Completed NCT02559583 Phase 4
9 Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands Completed NCT00731536 Phase 4
10 Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin’s Lymphoma Completed NCT00168727 Phase 4
11 Treatment of Peripheral T-cell Lymphoma Completed NCT01664975 Phase 4
12 Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL) Completed NCT00211198 Phase 4
13 PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy Completed NCT02805218 Phase 4
14 Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL) Completed NCT01007448 Phase 4
15 MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. Completed NCT00430352 Phase 4
16 German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults Completed NCT00199017 Phase 4
17 Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma Completed NCT00969462 Phase 4
18 Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients Completed NCT02108444 Phase 4
19 Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms Completed NCT01164475 Phase 4
20 Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL) Completed NCT00153530 Phase 4
21 Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma Completed NCT01124526 Phase 4
22 Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B Completed NCT00926757 Phase 4
23 LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV) Completed NCT00466258 Phase 4
24 Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients Completed NCT00050999 Phase 4
25 An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) Completed NCT02782845 Phase 4
26 Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients Completed NCT00051012 Phase 4
27 Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma Completed NCT00090038 Phase 4
28 Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy Completed NCT00230217 Phase 4
29 Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults Completed NCT00199082 Phase 4
30 Prevention of CHOP-induced Chronic Cardiotoxicity Completed NCT00162955 Phase 4
31 Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A Completed NCT00221039 Phase 4
32 Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) Completed NCT01418430 Phase 4
33 PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation Completed NCT00352703 Phase 4
34 Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia Completed NCT01374373 Phase 4
35 Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy Completed NCT00524407 Phase 4
36 Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture Completed NCT00808171 Phase 4
37 ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia Completed NCT00114348 Phase 4
38 DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor Completed NCT00029523 Phase 4
39 AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors Completed NCT00415103 Phase 4
40 Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation Completed NCT01339572 Phase 4
41 Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients Completed NCT00195533 Phase 4
42 A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer Completed NCT00277160 Phase 4
43 Subcutaneous Amifostine Safety Study Completed NCT00158041 Phase 4
44 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4
45 Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) Completed NCT00361140 Phase 4
46 Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation Completed NCT01738373 Phase 4
47 Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies Completed NCT01658280 Phase 4
48 LAL-BR/2001: Study Treatment to Low Risk ALL Completed NCT00526175 Phase 4
49 The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents Completed NCT02953730 Phase 4
50 To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma Recruiting NCT02585947 Phase 4

Search NIH Clinical Center for Lymphosarcoma

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Genetic Tests for Lymphosarcoma

Anatomical Context for Lymphosarcoma

MalaCards organs/tissues related to Lymphosarcoma:

39
Lymph Node, T Cells, Lung, Liver, B Cells, Colon, Bone Marrow

Publications for Lymphosarcoma

Articles related to Lymphosarcoma:

(show top 50) (show all 533)
id Title Authors Year
1
Association of BoLA-DRB3.2 Alleles with BLV Infection Profiles (Persistent Lymphocytosis/Lymphosarcoma) and Lymphocyte Subsets in Iranian Holstein Cattle. ( 26782666 )
2016
2
South African report of first case of chromoblastomycosis caused by Cladosporium (syn Cladophialophora) carrionii infection in a cat with feline immunodeficiency virus and lymphosarcoma. ( 25425600 )
2015
3
Massive Localized Lymphedema in the Morbidly Obese Patient: A Clinical Entity Mimicking Lymphosarcoma. ( 26367787 )
2015
4
Focal thoracolumbar spinal cord lymphosarcoma in a ferret (Mustela putorius furo). ( 24982519 )
2014
5
Cloacolithiasis and intestinal lymphosarcoma in an African black-footed penguin (Spheniscus demersus). ( 25000718 )
2014
6
Monoclonal hyperglobulinemia in lymphosarcoma in a cockatiel (Nymphicus hollandicus) and a blue and gold macaw (Ara ararauna). ( 25055643 )
2014
7
The effect of novel rhenium compounds on lymphosarcoma, PC-3 prostate and myeloid leukemia cancer cell lines and an investigation on the DNA binding properties of one of these compounds through electronic spectroscopy. ( 25221731 )
2013
8
Lymphosarcoma in a captive bonnethead shark, Sphyrna tiburo (L.). ( 23121332 )
2013
9
A Bovine Lymphosarcoma Cell Line Infected with Theileria annulata Exhibits an Irreversible Reconfiguration of Host Cell Gene Expression. ( 23840536 )
2013
10
Feline small cell lymphosarcoma versus inflammatory bowel disease: diagnostic challenges. ( 23677821 )
2013
11
Dynamics of oxidative modification of proteins and specific structural features of blood plasma from animals with Pliss lymphosarcoma. ( 23658922 )
2013
12
Feline small cell lymphosarcoma versus inflammatory bowel disease: treatment and prognosis. ( 23814916 )
2013
13
Activation of Cathepsins B and L in Mouse Lymphosarcoma Tissue under the Effect of Cyclophosphamide Is Associated with Apoptosis Induction and Infiltration by Mononuclear Phagocytes. ( 24319737 )
2013
14
Thymic lymphosarcoma with brain involvement in a Holstein heifer. ( 22785125 )
2012
15
Idiopathic hemorrhagic pericardial effusion as a precursor to epicardial lymphosarcoma in three cows. ( 22676351 )
2012
16
Cyclophosphamide metabolite inducing apoptosis in RLS mouse lymphosarcoma cells is a substrate for P-glycoprotein. ( 22803083 )
2012
17
The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma. ( 23251817 )
2012
18
Respiratory distress due to retropharyngeal and neck swelling in a horse with mediastinal lymphosarcoma. ( 22581725 )
2012
19
Ultrasonographic findings in a cow with abomasal lymphosarcoma: case report. ( 21612590 )
2011
20
What is your diagnosis? Lymphosarcoma. ( 22216725 )
2011
21
Lymphosarcoma associated with Heterobilharzia americana infection in a dog. ( 21908377 )
2011
22
Computed tomography of a cat with primary intratracheal lymphosarcoma before and after systemic chemotherapy. ( 22058360 )
2011
23
Diagnosis of intraocular lymphosarcoma in a dog by use of a polymerase chain reaction assay for antigen receptor rearrangement. ( 21355805 )
2011
24
Proline rich polypeptide (PRP-1) increases the superoxide-producing and ferrihemoglobin reducing activities of cytochrome B(558) isoforms from human lymphosarcoma tissue cells. ( 21213045 )
2011
25
Morphologic changes in the tumor and liver in mice with transplanted RLS40 lymphosarcoma during increase of its drug resistance. ( 21113505 )
2010
26
The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy. ( 20470373 )
2010
27
What is your diagnosis? Pulmonary lymphosarcoma in a dog. ( 20392175 )
2010
28
Signalment and clinical complaints initiating hospital admission, methods of diagnosis, and pathological findings associated with bovine lymphosarcoma (112 cases). ( 20492490 )
2010
29
Multicentric T-cell lymphosarcoma in a white-tailed deer (Odocoileus virginianus). ( 19617490 )
2009
30
[The state of enzymatic redox system of glutathione in the blood of patients with lymphosarcoma (non-Hodgkin's lymphoma]. ( 19642581 )
2009
31
Specifically activated dendritic cells--cell-based vaccine against lymphosarcoma exhibiting multiple drug resistance phenotype. ( 20848912 )
2009
32
Canine lymphosarcoma: overcoming diagnostic obstacles and introduction to the latest diagnostic techniques. ( 18390105 )
2008
33
Diffuse intestinal T-cell lymphosarcoma in a yellow-naped Amazon parrot (Amazona ochrocephala auropalliata). ( 18776105 )
2008
34
Immunophenotyping of lymphosarcoma in South American camelids on six British premises. ( 17307369 )
2008
35
Comparison of core needle biopsy and fine-needle aspiration of enlarged peripheral lymph nodes for antemortem diagnosis of enzootic bovine lymphosarcoma in cattle. ( 17223756 )
2007
36
Association between renal hypoechoic subcapsular thickening and lymphosarcoma in cats. ( 17691636 )
2007
37
Cutaneous lymphosarcoma in a double yellow-headed Amazon parrot (Amazona ochrocephala oratrix). ( 18351007 )
2007
38
Reevaluation of the University of Wisconsin 2-year protocol for treating canine lymphosarcoma. ( 17339285 )
2007
39
Large granular intestinal lymphosarcoma and leukemia in a dog. ( 17824330 )
2007
40
Atypical presentation of cutaneous T-cell lymphosarcoma in a 19-month-old Holstein heifer. ( 17436911 )
2007
41
Managing the canine lymphosarcoma patient in general practice. ( 17966344 )
2007
42
What is your diagnosis? A case of intervertebral disc protrusion in a cat: lymphosarcoma. ( 16438699 )
2006
43
Hypernatremia and hyperlipidemia in a dog with central nervous system lymphosarcoma. ( 16955835 )
2006
44
Standing thoracoscopy in the diagnosis of lymphosarcoma in a horse. ( 16963717 )
2006
45
Multicentric T-cell lymphosarcoma in an alpaca. ( 16427596 )
2006
46
Regulation of activity of cathepsins B, L, and D in murine lymphosarcoma model at a combined treatment with cyclophosphamide and yeast polysaccharide. ( 15890239 )
2005
47
A case of bilateral renal lymphosarcoma with secondary polycythaemia and paraneoplastic syndromes of hypoglycaemia and uveitis in an English Springer Spaniel. ( 19754769 )
2005
48
Physical and functional interaction of DNA methyltransferase 3A with Mbd3 and Brg1 in mouse lymphosarcoma cells. ( 16322236 )
2005
49
Two cases of multicentric lymphosarcoma in swine: gross and histopathologic findings. ( 15825523 )
2005
50
Detection of bovine leukemia virus by in situ polymerase chain reaction in tissues from a heifer diagnosed with sporadic thymic lymphosarcoma. ( 15825504 )
2005

Variations for Lymphosarcoma

Expression for Lymphosarcoma

Search GEO for disease gene expression data for Lymphosarcoma.

Pathways for Lymphosarcoma

GO Terms for Lymphosarcoma

Biological processes related to Lymphosarcoma according to GeneCards Suite gene sharing:

(show all 11)
id Name GO ID Score Top Affiliating Genes
1 glutathione metabolic process GO:0006749 9.49 G6PD GSR
2 positive regulation of B cell proliferation GO:0030890 9.48 BCL2 PTPRC
3 T cell differentiation GO:0030217 9.46 BCL2 PTPRC
4 covalent chromatin modification GO:0016569 9.46 DNMT3A NR3C1 RRP8 SMARCA4
5 cellular response to glucose starvation GO:0042149 9.43 BCL2 RRP8
6 response to gamma radiation GO:0010332 9.4 BCL2 PTPRC
7 negative regulation of G1/S transition of mitotic cell cycle GO:2000134 9.37 BCL2 SMARCA4
8 negative regulation of reactive oxygen species metabolic process GO:2000378 9.32 BCL2 G6PD
9 pentose-phosphate shunt GO:0006098 9.26 G6PD H6PD
10 NADP metabolic process GO:0006739 8.96 G6PD H6PD
11 B cell proliferation GO:0042100 8.8 BCL2 CD40LG PTPRC

Molecular functions related to Lymphosarcoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 carbohydrate binding GO:0030246 9.33 CD22 G6PD H6PD
2 NADP binding GO:0050661 9.13 G6PD GSR H6PD
3 glucose-6-phosphate dehydrogenase activity GO:0004345 8.62 G6PD H6PD

Sources for Lymphosarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....